Predictors of failure of Helicobacter pylori eradication with the standard'Maastricht triple therapy'

Background: Triple therapy with proton pump inhibitor, clarithromycin and a moxicillin has recently been proposed in Maastricht as first-line treatment for H. pylori infection. Aim: To determine predictors of unsuccessful eradication. Methods: Two hundred and forty-eight patients underwent endoscopy with biop sies for rapid urease test, histology and culture with antibiotic susceptib ility tests, and C-13-UBT. All infected patients were given pantoprazole (4 0 mg b.d.), clarithromycin (500 mg b.d.) and amoxicillin (1 g b.d.) for 1 w eek. Eradication was assessed by UBT at 4-6 weeks after therapy. Results: One hundred and sixty-two of 248 patients (65%) were infected. Cul ture was positive in 144 (89%), Prevalence rates of metronidazole, clarithr omycin and amoxicillin resistance were 14, 8 and 3%, respectively. Eradicat ion rates (95% CI) were 63% (54.7-70.6) by intention-to-treat analysis and 67% (59.4-75.4) by per protocol analysis. Drug compliance was excellent and side-effects were mild. Age greater than or equal to 45 years (OR: 2.35, C I: 1.30-4.25), smoking (OR: 1.37, CI 1.01-1.87) and high pre-treatment UBT results (OR: 1.36, CI: 1.08-1.72) were independent predictors of eradicatio n failure. Gender, endoscopic findings, alcohol intake, and clarithromycin and amoxicillin resistance did not predict treatment failure. Conclusion: Despite the low prevalence of primary antibiotic resistance in our geographical area, triple therapy with pantoprazole, amoxicillin and cl arithromycin achieves low eradication rates. Smoking, age and pre-treatment UBT results are predictors of potential eradication failure.